Phil Whiting, PhD

CEO

Phil is a seasoned executive with years of experience leading businesses commercializing new technology, from clean tech to robotics, at large companies and startups. Phil has a PhD in chemistry from McGill University. 

Ricky Ghoshal, MBDC

VP, Business Development

Ricky is a dynamic biotech business development professional and was one of Glysantis' first employees. Ricky has a Bachelor's degree in Health Sciences and a Masters in Biomedical Discovery and Commercialization from McMaster University. 

JD de Jong, PhD

Director, R&D

JD is a versatile scientist and R&D director with experience in virology and immunology. He has done significant research in the field of oncolytic viruses. JD has a PhD in molecular and cellular biology from the University of Guelph. 

Anton Korenevski, PhD

Chief Scientist

Anton has 30+ years of experience in research and development. Anton originally discovered the science behind the NanoDendrix™ platform. Anton received his PhD from the Russian Academy of Sciences

Karl Klinger, PhD

Sr. Chemist

Karl is an organic chemist with expertise in carbohydrate chemistry and organic synthesis. Karl received his PhD from the University of Natural Resources and Life Sciences, Vienna and completed a post-doctoral fellowship at McGill University. 

Sarah Poynter, PhD

Molecular/Cell Biologist

Sarah is a cellular and molecular biologist with expertise in innate immunity and virology. Sarah received her PhD from the University of Waterloo.